Patents by Inventor Michael Murtaugh

Michael Murtaugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • antigens and methods of use
    Patent number: 10323069
    Abstract: A Senecavirus A polypeptide generally includes at least a portion of 151-434 of SEQ ID NO:1, amino acids 435-673 of SEQ ID NO:1, or amino acids 674-937 of SEQ ID NO:1. The Senecavirus A polypeptide may be used as a capture antigen in a method or device for detecting antibody that specifically binds to the Senecavirus A polypeptide. The Senecavirus A polypeptide may be used as a immunogen to vaccinate a subject having or at risk of having a Senecavirus A infection.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: June 18, 2019
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Michael Murtaugh, Cheryl Dvorak
  • SENECAVIRUS A ANTIGENS AND METHODS OF USE
    Publication number: 20180057541
    Abstract: A Senecavirus A polypeptide generally includes at least a portion of 151-434 of SEQ ID NO:1, amino acids 435-673 of SEQ ID NO:1, or amino acids 674-937 of SEQ ID NO:1. The Senecavirus A polypeptide may be used as a capture antigen in a method or device for detecting antibody that specifically binds to the Senecavirus A polypeptide. The Senecavirus A polypeptide may be used as a immunogen to vaccinate a subject having or at risk of having a Senecavirus A infection.
    Type: Application
    Filed: August 23, 2017
    Publication date: March 1, 2018
    Inventors: Michael Murtaugh, Cheryl Dvorak
  • Identifying virally infected and vaccinated organisms
    Publication number: 20070003570
    Abstract: This document provides methods and materials related to assessing organisms for the presence or absence of anti-virus antibodies. For example, this document provides methods and materials that can be used to determine whether or not an organism (e.g., a member of a swine species such as a pig) contains anti-PRRS virus antibodies. In other embodiments, this document provides methods and materials that can be used to determine if a particular organism received a vaccine version of a virus, was infected with a naturally-occurring version of the virus, or is naive with respect to the virus.
    Type: Application
    Filed: June 17, 2005
    Publication date: January 4, 2007
    Inventors: Michael Murtaugh, Craig Johnson